Indian drug regulators say Gennova's COVID-19 vaccine safe in early trials

Indian pharmaceutical firm Gennova Biopharmaceuticals' mRNA-based COVID-19 vaccine was found to be safe and effective in an early-stage study, the country's drug regulator said on Tuesday.

Health authorities have allowed the company to conduct further studies to test the vaccine's efficacy.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)